Change your cover photoUpload Change your cover photoUpload Change your cover photo Alexandra Nowbar This user account status is Approved About About Posts Posts Comments Comments Thoughts about the use of the Win Ratio in Cardiovascular Outcome Trials 1 year ago in: Blog, Epidemiology & Outcomes, Heart Failure no comments A Pragmatic Trial isn’t just a Simple Trial: An Interview with Colin Baigent about ADAPTABLE 1 year ago in: Prevention no comments Speculations on PARADISE-MI (sacubitril/valsartan post-MI) before the full results 1 year ago in: Epidemiology & Outcomes, Heart Failure, MI/ACS no comments Wishful Thinking About Revascularization for Stable Coronary Artery Disease 1 year ago in: Epidemiology & Outcomes, Interventional Cardiology 9 comments Meet Spironolactone and Eplerenone’s Cardio-kidney Cousin, Finerenone 1 year ago in: Blog, Diabetes, Epidemiology & Outcomes, Heart Failure no comments Preliminary Musings on PARADISE-MI (sacubitril-valsartan post MI) 1 year ago in: Blog, Epidemiology & Outcomes, Heart Failure no comments New Guidelines for Endpoints in Valve Intervention Trials: is it an autocracy? 1 year ago in: Blog, Epidemiology & Outcomes, Interventional Cardiology, Policy & Ethics, Surgery no comments Athletes’ hearts after COVID: the entity that wasn’t 1 year ago in: Epidemiology & Outcomes, Imaging, Policy & Ethics no comments “Breakthrough” devices – to fast-track or not to fast-track 1 year ago in: Heart Failure, Policy & Ethics no comments Colchicine and COVID-19: a Tale of Two Trials 1 year ago in: Blog, Epidemiology & Outcomes no comments load more posts
Login / Signup